Delhi has reported the first death due to dengue this year, while the number of cases of the vector-borne disease has mounted to over 720, according to a civic report
There are several candidates in the works - the Serum Institute of India, Bharat Biotech, and Zydus Cadila are working on either developing or manufacturing anti-malarial vaccines
The World Health Organization (WHO) said on Wednesday that it has recommended widespread use of the world's first malaria vaccine called RTS,S/AS01 (RTS,S) for children in sub-Saharan Africa.
These diseases account for more than 17 per cent of all infectious diseases, causing over seven lakh deaths across the world annually.
Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
New mutations in the malaria parasite that enhance resistance to a drug used to prevent the disease in pregnant women and children are already common, says a new study
61% Indians know someone who died of Covid, will vaccine revive international travel, 22 experts on how to prevent future pandemics-news relevant to India's fight against Covid-19
Health and general insurers will soon be permitted to offer specific insurance cover to the public for treatment of vector-borne diseases like dengue, malaria and chikungunya
The India Meteorological Department (IMD) will start issuing forecast for malaria outbreaks from next monsoon, Ministry of Earth Sciences secretary M Rajeevan said on Saturday
Deaths from these three diseases could almost double over the next year as a result of disruptions to health care in the face of Covid-19
The BJP-ruled civic bodies launched a mega campaign in the city against dengue, chikungunya and malaria in view of the monsoon season and mosquito breeding
HCQ was dropped from the solidarity trial that WHO was conducting as a part of a global effort in May.
The global number of those infected with coronavirus has increased by almost 85,000 in the past 24 hours, climbing to 2,804,796 Covid-19 cases
Trump administration has stockpiled more than 30 million doses of hydroxychloroquine, a large chunk of which has been imported from India
Covid-19 has triggered a sense of urgency to revive this sick unit, as Hydroxychloroquine, an anti-malarial drug, surfaced as potential medicine to alleviate the symptoms of the disease
On March 25, India banned the export of hydroxychloroquine, which is used primarily to treat malaria and lupus
HCQ is the same drug that US President Donald Trump had sought from India and warned of retaliation if India did not supply the drug
There are currently no approved treatments, or preventive vaccines for Covid-19, the highly contagious, sometimes deadly respiratory illness caused by the new coronavirus
A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history's deadliest and most stubborn of diseases. The southern African nation is rolling out the shots in an unusual pilot programme along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it's worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa. Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with
All year round, the level of air pollution in Delhi remains three times higher than the national standard